That is the question...four things that I can think of could happen in 2013:

1) We get the long awaited FDA approval  and the stock takes off to 0.50 cents or higher.

2) Private placement, further dilution, more delusional investors join the circus.

3) The Private placement (if any) does not go through, the stock gets delisted.

4) 2 or 3 with a happy ending.  Large pharmaceuticals company purchases Medmira with an offer that you cannot refuse...

Please vote as to which one is most likely.  Let's have some guesses/fun